HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John D Meeker Selected Research

Pregnancy Complications

10/2022Urinary metals and maternal circulating extracellular vesicle microRNA in the MADRES pregnancy cohort.
1/2022Maternal blood metal concentrations are associated with matrix metalloproteinases (MMPs) among pregnant women in Puerto Rico.
1/2022Biomarkers of Exposure to Phthalate Mixtures and Adverse Birth Outcomes in a Puerto Rico Birth Cohort.
1/2021Maternal Urinary Metal and Metalloid Concentrations in Association with Oxidative Stress Biomarkers.
1/2021Maternal Metals/Metalloid Blood Levels Are Associated With Lipidomic Profiles Among Pregnant Women in Puerto Rico.
1/2021Individual and joint effects of phthalate metabolites on biomarkers of oxidative stress among pregnant women in Puerto Rico.
1/2021Psychosocial status modifies the effect of maternal blood metal and metalloid concentrations on birth outcomes.
1/2021Association of biomarkers of exposure to metals and metalloids with maternal hormones in pregnant women from Puerto Rico.
9/2020Investigating the impact of Hurricane Maria on an ongoing birth cohort in Puerto Rico.
2/2020An exploratory analysis of urinary organophosphate ester metabolites and oxidative stress among pregnant women in Puerto Rico.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John D Meeker Research Topics

Disease

33Premature Birth (Birth, Premature)
01/2022 - 10/2009
18Pregnancy Complications
10/2022 - 02/2013
17Inflammation (Inflammations)
01/2022 - 07/2011
13Birth Weight (Birth Weights)
01/2022 - 10/2012
9Spontaneous Abortion (Miscarriage)
01/2020 - 09/2007
8Pre-Eclampsia (Preeclampsia)
10/2021 - 09/2014
4Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 07/2010
3Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2021 - 01/2014
3Obesity
01/2021 - 05/2010
3Gestational Diabetes (Gestational Diabetes Mellitus)
01/2019 - 11/2016
3Gestational Weight Gain
01/2019 - 11/2016
3Infertility (Sterility)
02/2013 - 09/2011
2Chromosome Aberrations (Chromosome Abnormalities)
01/2019 - 11/2015
2Fetal Weight
01/2018 - 09/2016
2Overweight
01/2018 - 03/2011
2Type 2 Diabetes Mellitus (MODY)
11/2016 - 01/2016
2Insulin Resistance
01/2016 - 09/2012
2Fetal Growth Retardation (Intrauterine Growth Retardation)
09/2014 - 09/2014
2Preterm Premature Rupture of the Membranes
09/2014 - 01/2014
2Premature Obstetric Labor (Premature Labor)
09/2014 - 01/2014
2Chronic Disease (Chronic Diseases)
01/2014 - 09/2013
1Sleep Apnea Syndromes (Sleep Apnea)
01/2022
1Asthma (Bronchial Asthma)
01/2022
1Atherosclerosis
11/2021
1Pediatric Obesity
01/2021
1Hyperglycemia
01/2021
1Hypertension (High Blood Pressure)
01/2021
1Hypertriglyceridemia
01/2021

Drug/Important Bio-Agent (IBA)

33Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2011
31phthalic acid (phthalate)IBA
01/2022 - 10/2009
10bisphenol AIBA
01/2019 - 07/2010
8MetalsIBA
01/2022 - 11/2010
8PhenolsIBA
01/2021 - 01/2013
8C-Reactive ProteinIBA
10/2018 - 07/2011
7Endocrine DisruptorsIBA
01/2021 - 01/2016
6Diethylhexyl Phthalate (DEHP)IBA
01/2022 - 04/2013
6ParabensIBA
01/2021 - 03/2015
5Biological ProductsIBA
11/2021 - 01/2015
5Glucose (Dextrose)FDA LinkGeneric
01/2019 - 09/2012
4CadmiumIBA
01/2022 - 12/2013
4Heavy MetalsIBA
01/2022 - 01/2014
4CytokinesIBA
10/2018 - 01/2015
48-Hydroxy-2'-DeoxyguanosineIBA
10/2018 - 06/2014
48-epi-prostaglandin F2alphaIBA
01/2017 - 06/2014
4SmokeIBA
02/2013 - 09/2007
3PesticidesIBA
01/2022 - 10/2012
3MercuryIBA
01/2022 - 01/2019
3Triclosan (pHisoHex)FDA Link
01/2021 - 03/2015
3ManganeseIBA
01/2021 - 01/2019
3Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
02/2019 - 01/2017
3Thyroid HormonesIBA
01/2019 - 07/2010
3Persistent Organic PollutantsIBA
01/2014 - 10/2012
22-methyl-5,6-cyclopentapyrimidineIBA
01/2022 - 01/2014
2Hormones (Hormone)IBA
01/2022 - 05/2010
2mono-isobutyl phthalateIBA
01/2022 - 11/2019
2monobutyl phthalateIBA
01/2022 - 11/2019
2LipidsIBA
01/2022 - 11/2019
2mono-(2-ethylhexyl)phthalateIBA
01/2022 - 01/2014
2NickelIBA
01/2022 - 01/2021
22,5-dichlorophenolIBA
01/2021 - 01/2019
2monoethyl phthalateIBA
01/2021 - 10/2016
2ArsenicIBA
01/2020 - 12/2018
2bis(4-hydroxyphenyl)sulfoneIBA
01/2019 - 01/2019
2OrganophosphatesIBA
01/2019 - 01/2018
2IsoprostanesIBA
10/2018 - 03/2015
2pentabromodiphenyl ether (PBDE)IBA
01/2017 - 09/2012
2Alkaline PhosphataseIBA
01/2017 - 01/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 03/2015
2Interleukin-10 (Interleukin 10)IBA
09/2014 - 06/2014
2Interleukin-6 (Interleukin 6)IBA
09/2014 - 06/2014
2GonadotropinsIBA
07/2014 - 03/2011
2Environmental Pollutants (Pollutants, Environmental)IBA
01/2014 - 01/2013
2IronIBA
12/2013 - 01/2012
2Ferritins (Ferritin)IBA
12/2013 - 01/2012
2Drinking WaterIBA
01/2013 - 03/2012
2Halogenated Diphenyl EthersIBA
09/2012 - 07/2010
2CotinineIBA
05/2012 - 06/2011
2Polychlorinated Biphenyls (PCBs)IBA
07/2011 - 07/2010
1MicroRNAs (MicroRNA)IBA
10/2022
1TinIBA
01/2022
1CobaltIBA
01/2022
1Matrix Metalloproteinases (MMPs)IBA
01/2022
1mono(carboxy-isooctyl)phthalateIBA
01/2022
1suberic acidIBA
01/2022
1Fatty Acids (Saturated Fatty Acids)IBA
01/2022
1MolybdenumIBA
01/2022
1AntimonyIBA
01/2022
1perfluorooctane sulfonic acidIBA
10/2021
1ORALIT (ORS)IBA
10/2021
1perfluorodecanoic acidIBA
10/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1Dibutyl Phthalate (Butyl Phthalate)IBA
01/2021
1Nonesterified Fatty Acids (NEFA)IBA
01/2021
1Phosphatidylethanolamines (Cephalins)IBA
01/2021
1Tobacco Smoke Pollution (Passive Smoking)IBA
01/2021
12,4-dichlorophenolIBA
01/2021
1ElementsIBA
01/2021
1aminomethylphosphonic acid (AMPA)IBA
01/2021
1Glyphosate (Roundup)IBA
01/2021

Therapy/Procedure

2Duration of Therapy
07/2014 - 03/2011